Over 20 years of experience dedicated to intraocular lenses manufacturing To design, develop and distribute innovative solutions in eye surgery contributing to patient well-being. We have over 20 years of experience dedicated to IOL manufacturing. Opthalmology, Intraocular Lenses, Medical Devices, Surgical, Cataract, Vitreoretinal, and Cornea

42 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Securing your vision Recornea is a clinical stage medtech ophthalmic company developing therapeutic solutions for treating diseases of the cornea, such as keratoconus, glaucoma and corneal transplants.

85 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, drug free pain relief, pain relief, laser therapy, alternative medicine, Chiropractic, dentistry, physical therapy, pain management, superpulsed lasers, therapeutic lasers, sports medicine, medical devices, and technology

92 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Developing a new class of supraciliary implant for treating glaucoma CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably with a novel design. Founded in 2017 by ophthalmic surgeon and inventor Dr. Philippe Sourdille and Olivier Benoit, a veteran engineer and biotech entrepreneur, CILIATECH developed the CID (Cilio-scleral Inter-positioning Device) groundbreaking concept ‘CID’ is the first implant in the industry to reduce IntraOcular Pressure (IOP) without needing to access the anterior chamber or create a subconjunctival filtration bleb. The device is implanted as a standalone procedure …

6 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases. Our mission is to develop life-changing solutions for patients with diseases leading to sight loss.

82 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creating value in eye health for our patients worldwide VISUfarma is a pan-European ophthalmic pharmaceutical company with a clear mission: to bring quality products and global therapeutic innovation to European eye health. We are an ambitious and fast growing ophthalmology company, commercializing a broad portfolio of pharmaceutical products and medical devices across Europe. (www.VISUfarma.com). The company was formed in 2016 and is the result of the successful combination of the Italian company Visufarma SpA and the commercial activities of the international Nicox SA, headquartered in France. The combination created VISUfarma. We offer a complete portfolio of products in the areas …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.

160 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

518 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise.

161 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology New Materials

Innovating vision RhyGaze AG is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness. pharmaceutical development, optogenetics, gene therapy, ophthalmology, and pharmaceutical research

116 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases.

220 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases

338 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Développement analytique, Etudes de stabilité, Affaires technico-réglementaires, Consulting & expertise, Troubleshooting (pré et post AMM), Etudes précliniques et cliniques vétérinaires, Analytical method development, ICH validation, Stability study, and Quality Control GMP

94 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development

82 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.

62 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients.

382 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the …

7 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Research center & amp; Health development Bionoveo offers project leaders, industrial or academic, biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

285 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico

126 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Visionary Care Since 1935 always committed to improve patients’ quality of vision. SIFI is expanding into international market providing innovative solutions for ocular diseases. Eye Care, Pharmaceutical/Nutraceuticals/Medical Devices, Surgical & Diagnostic Medical Devices., Ophthalmology , Science, Researchers , Research, Vision, Eyes, Surgical, Medical technology, Health, Medicine , Eye health , and Biotech

61 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

610 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology